Approved podcast artwork
Science

Approved

by Alex Kesin and Matthew Pech

Today: #125 in Science on our combined chart.

Share this ranking Claiming needs an RSS feed. Contact us.

Chart positions today

If you like Approved, try…

Ranking history

History builds daily. We started tracking this show on the Science chart recently, so the trend line appears after a second day of data.
View as table
DateApple Podcasts
Oct 3#104

About the show

Life sciences, under the hood. Deep dives into the patent filings, regulatory gauntlets, and capital-risks that shape the business of biology.

Latest episodes

  • Allergan: Botox, Rogue Scientists, and the Ultimate Beauty Franchise

    September 18, 2026 · 3 hr 37 min

    The wild story of how a Cold War bioweapon became Botox — and how Allergan turned a sleepy ophthalmology drug into an enduring aesthetic franchise. Every part of this story looks nothing like your normal blockbuster drug. Botox started its…

  • What is Approved?

    September 14, 2026 · 3 min

    Approved tells the definitive stories behind the world's most interesting biotech ventures.  Most people learn about the industry in a fragmented, ad hoc way-- an industry article here, a clinical trial readout there, some science…

  • Blueprint Medicines: Chasing Gleevec to a $9B Allergy Drug

    August 4, 2026 · 2 hr 30 min

    Blueprint Medicines was built to find the next Gleevec-style cancer drug. It ended up pivoting to allergic disease instead, and selling to Sanofi for $9B. This is the platform, the pivot, and who got paid. Blueprint Medicines set out to be…

  • Keytruda: How Merck's Pembrolizumab Became the Best-Selling Cancer Drug of All Time

    May 14, 2026 · 2 hr 8 min

    Keytruda is Merck's $31 billion a year PD-1 inhibitor and the best-selling cancer drug of all time. In Episode 3 of Approved, Alex Kesin and Matthew Pech trace the development of pembrolizumab , featuring interviews the scientists who…

  • Episode #2: Geron

    March 13, 2026 · 2 hr 22 min

    Listen on Spotify Listen on Apple Podcasts Listen on YouTube TABLE OF CONTENTS (00:00:00) - Introduction  (00:01:19) - Hayflick Limit  (00:08:30) - Michael West & Founding of Geron  (00:15:16) - Early Science & IP Strategy  (00:27:25)…

  • Episode #1: Amylin Pharmaceuticals

    January 30, 2026 · 1 hr 46 min

    Listen on Spotify Listen on Apple Podcasts Listen on YouTube TABLE OF CONTENTS (00:00:00) - Introduction (00:04:40) - $50 of Dried Lizard Venom (00:29:17) - Fax of Death (00:43:04) - Sleeping Beauty Awakens (00:52:07) - Carl Icahn Sends a…